Cargando…

Activation of FXR protects against renal fibrosis via suppressing Smad3 expression

Renal fibrosis is the common pathway of most chronic kidney disease progression to end-stage renal failure. The nuclear receptor FXR (farnesoid X receptor), a multiple functional transcription factor, plays an important role in protecting against fibrosis. The TGFβ-Smad signaling has a central role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Kai, He, Jialin, Zhang, Yan, Xu, Zhizhen, Xiong, Haojun, Gong, Rujun, Li, Song, Chen, Shan, He, Fengtian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112546/ https://www.ncbi.nlm.nih.gov/pubmed/27853248 http://dx.doi.org/10.1038/srep37234

Ejemplares similares

FXR induces SOCS3 and suppresses hepatocellular carcinoma
por: Guo, Fei, et al.
Publicado: (2015)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways
por: Geng, Xiao-qiang, et al.
Publicado: (2019)

Activation of Pancreatic Acinar FXR Protects against Pancreatitis via Osgin1-Mediated Restoration of Efficient Autophagy
por: Zheng, Yufan, et al.
Publicado: (2022)

Iodine-125 Seeds Inhibit Carcinogenesis of Hepatocellular Carcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via TGF-β1/Smad Signaling
por: Yang, Chongshuang, et al.
Publicado: (2022)

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
por: Zhong, Xiaolin, et al.
Publicado: (2020)

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Zhou, Jiyu, et al.
Publicado: (2020)

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells
por: Xiong, Haojun, et al.
Publicado: (2017)

Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
por: Wang, Hui, et al.
Publicado: (2022)

Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy
por: You, Yong-Ke, et al.
Publicado: (2021)

Role of FXR in Renal Physiology and Kidney Diseases
por: Guo, Yanlin, et al.
Publicado: (2023)

Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway
por: Yang, Ji Hye, et al.
Publicado: (2021)

TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015)

Smad3 Signatures in Renal Inflammation and Fibrosis
por: Wu, Wenjing, et al.
Publicado: (2022)

P311 promotes renal fibrosis via TGFβ1/Smad signaling
por: Yao, Zhihui, et al.
Publicado: (2015)

A Compound of Chinese Herbs Protects against Alcoholic Liver Fibrosis in Rats via the TGF-β1/Smad Signaling Pathway
por: Li, Xiaomeng, et al.
Publicado: (2019)

SIRT2 alleviated renal fibrosis by deacetylating SMAD2 and SMAD3 in renal tubular epithelial cells
por: Yang, Shu, et al.
Publicado: (2023)

The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway
por: Zhang, Yue, et al.
Publicado: (2022)

MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7
por: Luo, Xufeng, et al.
Publicado: (2018)

Bile Acids, Microbiota, and Cystic Fibrosis: Channeling Intestinal FXR Signals
por: McHenry, Scott, et al.
Publicado: (2019)

let-7a suppresses liver fibrosis via TGFβ/SMAD signaling transduction pathway
por: Zhang, Yinghui, et al.
Publicado: (2019)

Acupuncture attenuates renal interstitial fibrosis via the TGF-β/Smad pathway
por: Zuo, Zheng, et al.
Publicado: (2019)

Liver Capsule: FXR agonists against liver disease
por: Fuchs, Claudia D., et al.
Publicado: (2016)

Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes
por: Zhang, Jiahui, et al.
Publicado: (2021)

Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
por: Lan, Hui Yao
Publicado: (2011)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023)

Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3
por: Zhou, Ning, et al.
Publicado: (2017)

Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression
por: Yu, Chao, et al.
Publicado: (2021)

Huangqi Shengmai Yin Protects against Radiation-Induced Cardiac Fibrosis Injury by Regulating the TGF-β1/Smads and MMPs
por: Gu, Jing, et al.
Publicado: (2019)

Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis
por: Seet, Li-Fong, et al.
Publicado: (2015)

Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7
por: Lee, Hyun, et al.
Publicado: (2022)

Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway
por: Zhao, Kaochang, et al.
Publicado: (2023)

Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022)

Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway
por: Chen, Lisheng, et al.
Publicado: (2021)

Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites
por: Wang, Yan-Ni, et al.
Publicado: (2021)

Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation
por: Chen, Wei, et al.
Publicado: (2019)

Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation
por: Wu, Weifeng, et al.
Publicado: (2021)

Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction
por: Soji, Kotaro, et al.
Publicado: (2018)

Thymoquinone protects the rat kidneys against renal fibrosis
por: Bargi, Rahimeh, et al.
Publicado: (2017)

siRNAs targeted to Smad4 prevent renal fibrosis in vivo
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4d1c56dtqluobi6fidgp578r9v